SLC18B1 Knockout HCT 116 Cell Line
Cat.No.:
EDC08602
Species:
Human
Cell Name:
HCT 116
Gene:
SLC18B1
Gene ID:
116843
Size:
1×10⁶cells
SLC18B1 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08602 |
|---|---|
| Product Name | SLC18B1 Knockout HCT 116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC18B1 |
| NCBI Gene ID | |
| Gene Synonyms | C6orf192|VPAT|dJ55C23.6 |
| Summary |
This gene encodes a protein, which has high sequence similarity to rat, xenopus and zebrafish proteins. The protein function is unknown. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Colorectal Carcinoma |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC18B1 function, SLC18B1 Knockout HCT 116 Cell Line or SLC18B1 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC18B1's role as a putative polyamine vesicular transporter or its emerging functions in lysosomal/endosomal storage. The Knockout line is appropriate for asking whether SLC18B1 is required for the vesicular accumulation of polyamines (spermine, spermidine) — SLC18B1 is the most recently identified SLC18 family member with proposed polyamine transport activity. Overexpression is useful for testing transport activity or for substrate identification.
For polyamine biology research, the EDITGENE SLC18B1 Knockout in HCT 116 enables study of vesicular polyamine handling in a cancer context — polyamines are essential for proliferating cells, including colorectal cancer cells. Rescue with wild-type or transport-deficient SLC18B1 is the standard specificity control. SLC18A1 (VMAT1) and SLC18A2 (VMAT2) paralog expression analysis aids interpretation given the family's vesicular transport biology.
What are the application scenarios for this model?
Primary applications:
• Polyamine uptake assays: ³H-spermine, ³H-spermidine uptake studies to quantify SLC18B1-dependent transport.
• Lysosomal/endosomal localization: imaging-based analysis to characterize SLC18B1 compartmental distribution.
• Cancer cell polyamine handling: assessment of polyamine pools in proliferating colorectal cancer cells with disrupted SLC18B1.
• SLC18 family studies: VMAT1 (SLC18A1) and VMAT2 (SLC18A2) expression analysis for paralog-specific characterization.
EDITGENE recommends this model for researchers investigating SLC18 family transporter biology and cellular polyamine homeostasis.
Is this SLC18B1 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes, with attention to vesicular targeting:
• Construct design: use a codon-modified SLC18B1 sequence with a small C-terminal tag (FLAG, HA). SLC18B1 has 12 transmembrane domains in the canonical SLC18 architecture.
• Vesicular localization validation: confirm intracellular vesicular localization by imaging before functional assays.
• Transport-deficient rescue: substrate-binding mutations enable distinguishing predicted polyamine transport from other functions.
• Functional readout: rescue should restore phenotypes identified during knockout characterization (polyamine handling, vesicular function).
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.